Literature DB >> 7216428

Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro.

J K Davis, K M Delozier, D K Asa, F C Minion, G H Cassell.   

Abstract

In comparison to syngeneic fibroblasts, alveolar macrophages collected from Fischer 344 rats demonstrated a significant ability to decrease the growth rate of cell-associated Mycoplasma pulmonis, even in the absence of specific actimycoplasmal antibodies. However, when exposed to thallium acetate (a cytotoxic heavy metal), macrophages supported growth of mycoplasmas almost as well as did untreated fibroblasts. This suggests an active antimycoplasmal process operative in untreated macrophages. In contrast, mouse alveolar macrophages were not capable of exerting an antimycoplasmal effect unless rabbit anti-M. pulmonis antibodies were present. Paradoxically, mouse anti-M. pulmonis antibodies did not promote this effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216428      PMCID: PMC551163          DOI: 10.1128/iai.29.2.590-599.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  The structure and function of monocytes and macrophages.

Authors:  Z A Cohn
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

2.  Comparison of the pulmonary bactericidal capacity of mice and rats against strains of Pseudomonas aeruginosa.

Authors:  P M Southern; A K Pierce; J P Sanford
Journal:  Appl Microbiol       Date:  1971-02

3.  The isolation and comparative biological and physical characteristics of T-mycoplasmas of cattle.

Authors:  D Taylor-Robinson; M H Williams; D A Haig
Journal:  J Gen Microbiol       Date:  1968-11

4.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

5.  A modified assay of neutrophil function: use of lysostaphin to differentiate defective phagocytosis from impaired intracellular killing.

Authors:  J S Tan; C Watanakunakorn; J P Phair
Journal:  J Lab Clin Med       Date:  1971-08

6.  Two antigenically different types of macrophages.

Authors:  I Montfort; R Pérez Tamayo
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

7.  Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis.

Authors:  J R Lindsey; H J Baker; R G Overcash; G H Cassell; C E Hunt
Journal:  Am J Pathol       Date:  1971-09       Impact factor: 4.307

8.  Immunofluorescence identification of Mycoplasma on agar by use of incident illumination.

Authors:  R A Del Giudice; N F Robillard; T R Carski
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

9.  Antitumor activity and toxicity of salts of inorganic group 3a metals: aluminum, gallium, indium, and thallium.

Authors:  M M Hart; R H Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  21 in total

1.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection.

Authors:  Judy M Hickman-Davis; Carmel McNicholas-Bevensee; Ian C Davis; He-Ping Ma; Glenda C Davis; Charles A Bosworth; Sadis Matalon
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

3.  Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.

Authors:  J M Hickman-Davis; J R Lindsey; S Matalon
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

6.  Effect of time of exposure to rat coronavirus and Mycoplasma pulmonis on respiratory tract lesions in the Wistar rat.

Authors:  M K Schunk; D H Percy; S Rosendal
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

7.  Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice.

Authors:  J K Davis; R F Parker; H White; D Dziedzic; G Taylor; M K Davidson; N R Cox; G H Cassell
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma.

Authors:  Wees Love; Nicole Dobbs; Leslie Tabor; Jerry W Simecka
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination.

Authors:  F C Minion; G H Cassell; S Pnini; I Kahane
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.